Post-Market Study of the ICONACY Hip System
ICONACY Hip Clinical Data Acquisition (13-1-M-239)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- This must be a primary hip replacement on this hip
- Patient is 30 years of age or older
- Have hip joint disease related to one or more of the following: degenerative joint disease, including osteoarthritis or traumatic arthritis
- Patient is likely to be available for evaluation for the duration of the study
- Able and willing to sign the informed consent and follow study procedures
Exclusion Criteria:
- Is younger than 30 years of age
- If there has been a total hip replacement on this hip in the past (no revisions allowed in study)
- Infection, or history of infection, acute or chronic, local or systemic
- Alcoholism or other addictions
- Muscular, neurological or vascular deficiencies which compromise the affected extremity
- Obesity(BMI>45)
- Insufficient bone quality
- Loss of ligamentous structures
- High levels of physical activity
- Materials sensitivity
- Prisoner
- Mental conditions that may interfere with the patient's ability to give an informed consent or willingness to fulfill the study requirements
- Patient is pregnant
- Is not able to read English language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Iconacy Hip System
Iconacy hip system prosthesis components
|
Comparison of Iconacy I-Hip system to the Stryker Accolade hip system using a randomized study.
Other Names:
|
|
ACTIVE_COMPARATOR: Stryker Accolade Hip System
Stryker Accolade hip system prosthesis components
|
Comparison of Iconacy I-Hip system to the Stryker Accolade hip system using a randomized study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Radiographic success
Time Frame: 2 years
|
2 years
|
|
Harris Hip Score must be > or = 80 at 2 years
Time Frame: 2 years
|
2 years
|
|
Oxford Hip Score > 40 points at 2 years
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Patient Satisfaction at 1, 2, and 3 years
Time Frame: 1, 2, and 3 years
|
1, 2, and 3 years
|
|
Improvement in Harris Hip Score from pre-surgery to 1, 2, and 3 years
Time Frame: 1, 2, and 3 years
|
1, 2, and 3 years
|
|
Improvements in Oxford Hip Score from pre-survey to 1, 2, and 3 years
Time Frame: 1, 2, and 3 years
|
1, 2, and 3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: William A Hodge, MD, Eastern Maine Medical Center
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 13-1-M-239
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.